Related Experiment Videos
[Effectiveness and tolerance of piperacillin in 333 patients]
Abstract:
In a French multicentric trial the effectiveness and safety of piperacillin were evaluated in 333 patients with severe infections. Piperacillin was administered alone in 212 cases. The overall results show that the drug was clinically effective in 85% of the patients. The results of this French study are similar to those of other studies previously published. They demonstrate an increase in the number of failures against ampicillin-resistant and carbenicillin-resistant strains, even when these strains were sensitive to piperacillin in vitro. Piperacillin was tolerated as well as the other beta-lactam antibiotics, the main side-effects being hypersensitivity reactions.
Insights
Piperacillin demonstrated 85% clinical effectiveness in severe infections. However, failures occurred with resistant strains, and side effects were similar to other beta-lactam antibiotics.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Severe infections pose significant treatment challenges.
- Piperacillin is a beta-lactam antibiotic used for bacterial infections.
- Evaluating new antibiotic effectiveness is crucial for patient care.
Purpose of the Study:
- To assess the clinical effectiveness and safety of piperacillin in patients with severe infections.
- To compare piperacillin's efficacy against ampicillin- and carbenicillin-resistant strains.
- To document adverse events associated with piperacillin treatment.
Main Methods:
- A French multicentric trial involving 333 patients with severe infections.
- Piperacillin administered as monotherapy in 212 cases.
- Clinical effectiveness and safety data collected and analyzed.
Main Results:
- Piperacillin achieved clinical effectiveness in 85% of patients.
- Increased treatment failures were observed with ampicillin- and carbenicillin-resistant strains, despite in vitro sensitivity.
- Piperacillin exhibited a safety profile comparable to other beta-lactam antibiotics, with hypersensitivity reactions being the primary adverse effect.
Conclusions:
- Piperacillin is an effective treatment option for severe infections, achieving high clinical success rates.
- Caution is advised when using piperacillin against strains resistant to other penicillins, even if sensitive in vitro.
- Piperacillin's safety profile is favorable, similar to existing beta-lactam antibiotics.